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Abstract
Purpose: Granulomatous slack skin (GSS) is a rare cutaneous disorder char-
acterized clinically by the evolution of circumscribed erythematous lax skin
masses, especially in the body folds, and histologically by a granulomatous
T-cell infiltrate and loss of elastic fibers. GSS is often associated with preceding
or subsequent lymphoproliferative malignancies, especially mycosis fungoides
(MF) and Hodgkin’s disease (HD). No effective treatment is known yet. Wheth-
er this entity is a benign disorder, a peculiar host reaction to a malignant lym-
phoma, a precursor of malignant lymphoma or an indolent cutaneous T-cell lym-
phoma (CTCL) in itself is still a matter of debate. Patients and Methods: The
results of the patients with GSS from the Netherlands are compared with the
cases reported in the world literature. Results: A female patient had had GSS for
8 years without developing a secondary malignancy. In a second female patient
with a histologically confirmed diagnosis of MF, GSS developed 18 years later
in the axillary and inguinal folds which had previously been affected by plaque-
stage MF lesions. A third male patient with a 6-year history of erythematosqua-
mous skin disease diagnosed as CTCL developed GSS. Moreover, granuloma
formation was also found in a facial basal cell carcinoma, in a cervical lymph
node and the spleen. Clonal rearrangements of the T-cell receptor b genes were
found in the 2 female patients; the male patient could not be tested. Conclusion:
GSS is a rare clinicopathological entity. Only 34 patients have been described so
far. The development of GSS within plaque MF lesions has not been reported
before. Our third case developed very extensive skin lesions and showed a
strong propensity to develop granulomas as compared to cases reported before.
The presence of a clonal T-cell population was demonstrated in all cases tested.
Our cases support the idea that GSS is a very rare and rather indolent type of
CTCL. Apparently, the disease is associated with a peculiar immune response,
characterized by granuloma formation and disappearance of elastic fibers result-
ing in the lax skin. The relationship between GSS and other preexisting or sub-
sequent lymphoproliferative diseases (diagnosed in approximately 50% of the
cases) warrants a life-long follow-up.
oooooooooooooooooooo
Introduction
Granulomatous slack skin (GSS) is a rare cutaneous
disorder, characterized by slowly progressive indurated
plaques which evolve into erythematous pendulous skin
folds, predominantly in the flexural areas and especially in
the inguinal and axillary region. In long-standing disease,
other skin areas can also become involved. Histological ex-
amination of early lesions shows a dense dermal infiltrate
consisting of small- to medium-sized normochromatic
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T lymphocytes and monocyte-derived nonneoplastic macro-
phages intermingled with eosinophils, and sometimes plas-
ma cells and B lymphocytes. Fully developed lesions also
show cells with larger hyperchromatic cerebriform nuclei
among tumor-infiltrating lymphocytes. As the most con-
spicuous feature, numerous epithelioid and giant cell gran-
ulomas occur in which phagocytized elastic fibers can be
found [1–3]. The disappearance of elastic fibers results in
lax skin. Follow-up data from all reported patients with
GSS reveal a relationship between GSS and a preexistent or
subsequent lymphoproliferative malignancy in about half
of the cases [3–11].
Molecular clonality studies of skin samples have been
reported in 8 patients [3, 8–13]. These studies revealed
clonal rearrangement of the T-cell receptor TCRb or TCRg
gene. Genotypic studies in 2 cases revealed trisomy 8 in
both of them [13, 14]. Therefore most authors suggest that
GSS in fact is an indolent cutaneous T-cell lymphoma
(CTCL) [3, 8–15].
We present 3 patients with GSS in the context of an up-
dated review of the literature. The purpose of this study is
to define a place for GSS among the known lymphoprolif-
erative disorders and to contribute to the discussion on the
pathobiology of GSS.
Case Reports
Case I
A 35-year-old Caucasian female patient presented in 1988 with
circumscribed nonitching, slightly scaling, slowly progressive skin
lesions in the right inguinal fold and on the right medial thigh. The
lesions had been present for 7 years and the skin showed a tendency
to hang in loose folds (fig.1a). Further physical examination revealed
no abnormalities. A skin biopsy specimen showed acanthosis, slight
parakeratosis and a dense dermal lymphocytic infiltrate with scattered
multinucleated giant cells. The lymphocytes had normal-sized, nor-
mochromatic, slightly irregular nuclei. Occasionally scattered eosin-
ophils were seen. Almost complete absence of elastic fibers was con-
firmed by Verhoeff-Van Gieson staining. Some giant cells contained
fragments of elastic fibers (fig.2).
The lymphocytes had the T-cell phenotype without loss of T-cell
markers [CD2 (TII)+, CD3 (leu-4)+ and CD5 (leu-1)+]. T cells with the
helper phenotype, CD4 (leu-3a), predominated over cells with the sup-
pressor phenotype, CD8 (leu-2a; CD2, Central Laboratory of the Nether-
lands Blood Transfusion Service, Amsterdam, the Netherlands, all other
antibodies from Becton-Dickinson, Mountain View, Calif., USA).
Molecular clonality studies on a skin specimen revealed clonal
TCRb and TCRg gene rearrangements in about 25% of the nucleated
cells in the biopsy; this corresponded with the relative size of the T-
cell infiltrate [16]. Also a clonal immunoglobulin heavy-chain (IgH)
gene rearrangement was found. This was interpreted as a cross-lin-
eage immunoglobulin gene rearrangement in the clonal T cells be-
cause the biopsy did not contain sufficient B lymphocytes to explain
the detection of a clonal IgH gene rearrangement [17].
A chest X-ray and a CT scan of the abdomen revealed no signs of
lymphoproliferative disease. Laboratory investigations were within
normal limits.
A diagnosis of GSS was made, based on the clinical and histolog-
ical data. The diseased skin in the groin was excised, but the skin le-
sions recurred. Lesions were treated topically with steroids of differ-
ent strengths and topical nitrogen mustard without success.
Treatment with psoralen-ultraviolet A resulted in partial remission
of early lesions on the buttocks and hips but had no effect on the le-
sions in the groins. During the 8-year follow-up period after the initial
GSS diagnosis the lesions slowly progressed. Duing the last half year
she was treated with intralesional interferon a which was not effec-
tive. However, no clinical or histological signs for the development of
a malignant lymphoproliferative disease were observed, in spite of the
clonal T cells in the skin infiltrate.
Case II
A 22-year-old Caucasian female patient with a history of psoriasis
vulgaris presented in 1975 with several red infiltrated well-demar-
cated scaling skin lesions which were diagnosed as mycosis fungoides
(MF). No enlarged lymph nodes were found.
The patient was treated with total skin electron beam irradiation
(4 MeV, 3,500 rad). This resulted in remission of all lesions except for
a lesion on the dorsum of the left foot.
From 1983, recurrences were treated with topical application of ni-
trogen mustard which resulted in partial remission.
In 1993, MF lesions involved the axillary and inguinal folds, the
lower quadrants of the abdomen, the mammae and flexural areas
(fig.1b). Sometimes papules and nodi were noticed within the lesions
during an exacerbation. Hanging laxy skin folds developed in the right
axilla and both inguinal folds within the preexisting MF lesions. A
skin biopsy specimen showed a granulomatous infiltrate (fig.3) with
small lymphocytes revealing epidermotropism and a dermal infiltrate
of lymphocytes with medium-sized irregular and hyperchromatic nu-
clei, histiocytes and scattered multinucleated giant cells, some of
which contained fragments of elastic fibers. The size of the lympho-
cytes was invariably much smaller than the MF cells found in earlier
biopsies (fig.4). Absence of elastin was confirmed by Verhoeff-Van
Gieson staining. Occasional eosinophils were seen.
All lesional lymphocytic cells had the T-cell phenotype (CD2+,
3+) with CD4+ cells predominating over CD8+ cells. The atypical
lymphocytes were CD5–.
Molecular clonality studies of a representative skin specimen from
the axilla revealed that approximately 20% of the nucleated cells in
the biopsy specimen contained a clonal TCRb gene rearrangement
which is consistent with the presence of 20–30% of atypical T lym-
phocytes. A diagnosis of GSS was made. For cosmetic reasons, a le-
sion of 3 · 5 cm was excised from the right axilla. The lesions in the
axillae have continued to progress, and on the abdomen GSS lesions
have appeared in areas which had previously been affected by MF.
Treatment with topical carmustine resulted in partial remission.
Case III
A 49-year-old Caucasian man developed slowly progressive infil-
trated erythematosquamous plaques on the lower half of the abdomen
and in the left axilla in 1962.
A skin biopsy specimen revealed atypical lymphocytes, histio-
cytes, eosinophils and some multinucleated giant cells of the Lang-
hans type. A diagnosis of eosinophilic granuloma was considered.
Therapy with prednisone and procarbazine was started but discontin-
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ued because of leukopenia. Treatment with busulfan and prednisone
resulted in partial remission. Three years later, the skin lesions had
progressed to paper-thin laxy skin folds. Several firm palpable lymph
nodes were present inguinally.
A punch skin biopsy revealed a diffuse dermal infiltrate composed
of small, normal T lymphocytes, histiocytes and eosinophilic granulo-
cytes with scattered multinucleated giant cells and granuloma forma-
tion. The giant cells contained fragments of elastin fibers.
The diagnosis of GSS was made. Treatment with prednisone
15 mg/day was started which slowed down the disease progress; low-
ering of the dosage resulted in fever and/or worsening of the skin con-
dition. One year later, an adenocarcinoma of the colon was diagnosed
and during surgery a grossly enlarged spleen was found. The spleen,
800 g, was removed and upon histological examination showed non-
caseating granulomas, comparable to those found in the skin. Liver
biopsies revealed no abnormalities.
384 Dermatology 1998;196:382–391 van Haselen/Toonstra/van der Putte/
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Fig. 1. a Right inguinal area with sharply demarcated red-brown
atrophic lax skin lesion in patient I. b Right axilla with a pendulous
fold of erythematous skin in previous mycosis fungoides plaque in pa-
tient II. c Extensive lax skin formation on the trunk in patient III.
Fig. 2. Elastin Verhoeff-van Gieson staining showing a multinu-
cleated giant cell with phagocytized elastic fibers in patient I. Original
magnification · 400.
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In the following years, several basal cell carcinomas and a squa-
mous cell carcinoma developed in the face. An enlarged lymph node
was found on the right side of his neck.
One of the basal cell carcinomas and the cervical lymph node
showed granuloma formation. Four years later in 1976, the patient
died at the age of 63 years of an unknown cause. At this time, his trunk
was covered with extremely sagged atrophic skin and several varicose
veins (fig.1c). On the extremities, many small infiltrated plaques were
present and in his neck firm lymph nodes were noticed. Permission for
autopsy was not granted.
Unfortunately, there was no material available for TCR gene clon-
ality studies.
Discussion
The three case histories contribute to the still ongoing de-
bate concerning the pathobiology of ‘GSS’ and the relation-
ship between GSS and other lymphoproliferative diseases,
especially MF and Hodgkin’s disease (HD). The first patient
presented with classical GSS without MF cells in the infil-
trate and no association with a lymphoproliferative malig-
nancy was found after 8 years follow-up. Molecular clonality
studies in this patient however showed clonal TCRb and
TCRg gene rearrangements in the T-cell infiltrate of the skin.
In the second female patient with a histologically con-
firmed diagnosis of MF, GSS developed in the preexisting
plaque-stage MF lesions in the axillary and inguinal folds.
Molecular clonality studies showed clonal rearrangement
of the TCRb genes, but we cannot officially exclude that
the finding of these clonal rearrangements was due to the
preexistent MF cells.
The third patient developed very extensive lax skin le-
sions over many years. In addition granulomas were found
in a basal cell carcinoma, in the enlarged spleen and in a
cervical lymph node.
History
Before Ackerman [1] in 1978 proposed the term granu-
lomatous slack skin (GSS), some cases have been reported
under other denominations.
In 1968, Bazex et al. [18] reported on a patient with a
skin and lymph node disorder characterized by hanging
skin masses in the body folds some of which had an ulcer-
ative course. On histology granulomas were found. The
case report was entitled ‘Maladie de Besnier-Boeck-Schau-
mann chalazodermique?’, but we have the opinion that this
case report represents the first case of GSS.
In 1973, Convit et al. [4] reported on a patient with a
‘progressive atrophying chronic granulomatous dermohy-
podermitis’. The onset of the disease in this particular case
started after the successive injection of Mitsuda antigen
(used for assessment of the cell-mediated response to My-
cobacterium leprae) and BCG vaccine. The patient devel-
oped papular lesions coalescing into plaques that showed a
tendency to hang in loose folds. One of the initial lesions
appeared at the site where the Mitsuda antigen had been in-
jected.
Histologically, in the lesions granulomas with lympho-
cytes, epithelioid cells, giant cells and histiocytes were
found [4, 18]. In 1978, the disease was further defined by
Ackerman [1] who proposed the term GSS, based on the
385Granulomatous Slack Skin Dermatology 1998;196:382–391
Fig. 3. Dense dermal granulomatous infiltrate in patient II. Original magnification · 40.
Fig. 4. Detail of infiltrate showing multiple Langhans giant cells, eosinophils and small lymphocytes in patient II.
Original magnification · 200.
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histological and clinical features [19]. In the French litera-
ture, the term ‘chalazodermie granulomateuse’ is used [6,
18, 20].
Since the report of Convit et al. [4] on GSS, 34 patients
(including the 3 patients in this report) have been described.
Sex and Age Distribution
The age of onset of GSS ranges from late childhood to
mid-adult life (range 14–69 years; mean age 37 years). The
time span between the start of the disease and the GSS
diagnosis may vary significantly. First biopsy specimens
were often taken when a patient presented with lax skin
formation, but in some reports CTCL/MF-like lesions had
been present for more than 10 years [20]. The male:female
ratio is about 2.3:1.
Only Caucasian patients with GSS have been described
so far.
Clinical Features
The features of 34 patients with GSS are summarized in
table 1.
At the onset, indurated plaques with swollen subcuta-
neous tissue are usually found, but papules and nonitching
erythematous scaling patches with poikiloderma vasculare
atrophicans have also been described [4, 6, 20, 33]. The le-
sions evolve into areas of hanging bulky skin masses. At
this stage, the skin surface starts to wrinkle and softens
[34]. In some patients ulceration may occur [10, 11, 13, 18].
When lesions become more atrophic, subcutaneous blood
vessels may become visible [34]. The inguinal and axillary
folds are most often affected, but in long-standing disease
other skin areas can also be involved. Unusual sites of in-
volvement include the back, hands and eyelids [3, 14, 34].
Histological Features
Early GSS lesions show a lymphohistiocytic band-like
infiltrate mainly confined to the upper dermis. The lympho-
cytes are small- to medium-sized with less convoluted and
less hyperchromatic nuclei than usually observed in classic
MF [6]. There is a loss of both papillary and reticular der-
mal elastic tissue (Verhoeff-Van Gieson staining).
Multinucleated giant cells with phagocytized elastic fi-
bers are the most conspicuous feature [8]. The granulomas
are noncaseating [34].
Fully developed lesions show small- to medium-sized
lymphoid cells permeating the entire dermis and also the
subcutis. The lymphoid cells have larger hyperchromatic
cerebriform nuclei comparable with classical MF cells [8,
34]. Atypical lymphoid cells with a tendency to epidermo-
tropism may be detected. Pautrier’s microabscesses have
been reported [3, 34] but are usually absent [3, 8, 33]. Mild
spongiosis (i.e. mild intra- and extracellular edema in the
epidermis) may occur [8, 13, 34].
The multinucleated giant cells in fully developed GSS
lesions are evenly distributed within the infiltrate [3]. The
nuclei of the giant cells are arranged randomly within the
cytoplasm (foreign-body giant cells), but arrangement
along the periphery of the cells has also been observed
(Langhans giant cells; case I) [8, 15, 34]. Eosinophils, B
lymphocytes and plasma cells may also be observed [15]
and were seen in cases I and II of the present study. Indica-
tions for the presence of apoptotic lymphocytes and lym-
phophagocytosis have been demonstrated by electron mi-
croscopy [3, 8, 11].
In the case presented by Le Boit [34], granulomatous ar-
teritis with both lymphocytes and giant cells within the in-
tima of an artery was observed.
In 1 patient with disseminated disease, infiltrates similar
to those in the skin were present in the submucosa of the
bronchi [34]. In case III, the GSS patient showed granu-
loma formation in a basal cell carcinoma and a cervical
lymph node, and lymph node involvement has also been
described in the case reported by Bazex et al. [18].
Immunohistochemistry
Immunophenotypic studies show that the lymphocytic
infiltrates mainly consist of CD4+/CD45RO+ T lympho-
cytes. Loss of T-cell markers (CD3, CD5, CD7) has been
reported [35]. Occasionally CD30 (ki-1)-positive cells have
been found [14].
The granulomatous component appears to be derived
from the monocyte-macrophage lineage as the multinucle-
ated giant cells express the monocytic CD14 antigen and
the macrophage CD68 antigen [3, 8, 12, 14, 32–34].
Rearrangement and Genotypic Studies
Southern blot analysis of the TCRb and TCRg genes in
GSS skin lesions has been carried out in 10 patients (table 1:
patients No. 3, 8, 9, 10, 13, 22, 29, 32, 33). The presence of
a clonal T-cell population was demonstrated in all cases
tested [8, 10, 34]. In cases 3 and 8, mononuclear cell frac-
tions tested in peripheral blood revealed no rearrangements
[8, 13]. In addition to clonal rearrangement of the TCRb
and TCRg genes in skin lesions a clonally rearranged IgH
gene was found in case I of this report; this has not been re-
ported in GSS so far. We concluded the presence of a single
T clone with both TCR and cross-lineage IgH gene rear-
rangements [16, 17].
This is in line with the observation that after 8 years fol-
low-up no secondary B-cell malignancy has developed. Tri-
386 Dermatology 1998;196:382–391 van Haselen/Toonstra/van der Putte/
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Table 1. Summary of all reported patients with granulomatous slack skin (n=34)
Case Ref. Sex/age Follow-up Associated LPD Additional remarks
No. at diagnosis years after
diagnosis
1 18 m/24 1 none granulomatous lymphadenitis
2 4 m/15 22 HD after GSS onset after Mitsuda test, died of HD
3 2, 13 m/39 15 none ulceration of lesions, trisomy 8, clonal rearrangement
4 5 m/21 ? HD after GSS died of HD
5 21 m/27 2 none
6 6 m/55 10 HD and GSS CR of HD with polychemotherapy, alive with GSS, HD and GSS
7 20 f/23 12 none
8 8 f/14 >10 none clonal rearrangement, dermatopathic lymphadenitis
9 8, 22 m/46 ? HD after GSS cutaneous HD within GSS lesion, clonal rearrangement
10 3, 8 m/42 ? NHL after GSS granulomatous infiltrates in lungs, died of NHL after relapse,
clonal rearrangement
11 7 m/41 >5 NHL before GSS PR of GSS following chemotherapy, CR of NHL
12 23, 24 f/25 >8 none gallium-67 uptake in lung lesions
13 12 m/20 >7 HD after GSS relapse of HD following chemotherapy, clonal rearrangement
14 12 m/30 small lymphocytic RD of NHL after excision/RT/topical nitrogen mustard
NHL after GSS
15 12 m/51 >8 none
16 25 m/24 mixed cellularity RD of GSS after excision
HD after GSS
17 26 f/56 ? none diabetes
18 27 m/30 15 nodular aclerosing HD died of leukemia, PR of GSS and HD due to polychemotherapy
after GSS, myelocytic
leukemia
19 28 f/22 2 none
20 29 m/69 10 none
21 30 f/43 7 LCH after GSS PR of LCH after prednisone
22 9 m/66 4 none clonal rearrangement
23 19 m/33 ? none
24 31 f/31 >5 GMF and GSS
25 32 m/29 >4 NHL after GSS chemotherapy: CR of NHL, PR of GSS
26 14 m/57 >7 none
27 14 m/53 >7 none
28 33 m/54 7 HD before GSS granulomatous lymphadenitis
29 10 m/49 >3 none clonal rearrangement, trisomy 8
30 15 m/38 >11 HD after GSS
31 11 m/24 5 GSS and MF alive with GSS and MF, clonal rearrangement
32 I f/28 8 none clonal rearrangement
33 II f/40 2 GSS after MF GSS within MF lesions, clonal rearrangement
34 III m/49 14 none adenocarcinoma of colon, granulomas in spleen and lymph node,
variety of skin malignancies, died with extensive GSS
LPD=Lymphoproliferative disease; NHL=non-Hodgkin’s lymphoma (nodal); LCH=Langerhans cell histiocytosis; CR=complete remis-
sion; PR =partial remission; RD=relapsing disease (after initial remission); RT=radiotherapy; I, II, III=presented case reports.
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somy of chromosome 8 which is known to play a role in the
pathogenesis of HD, non-Hodgkin’s lymphomas, some
leukemias and Ewing’s sarcoma has been observed in a
skin cell culture obtained from 2 patients with GSS [10,
13].
Comparative cytogenetic studies of GSS and associated
preexistent and subsequent lymphoproliferative disorders
have not been reported yet.
Extracutaneous Involvement
Extracutaneous involvement of GSS rarely occurs.
Granulomatous lymphadenitis has been reported in 3 pa-
tients [18, 33]. Case III of this report showed granuloma
formation in an enlarged cervical lymph node and in the en-
larged spleen.
In one patient with disseminated GSS, infiltrates similar
to those in the skin were present in the submucosa of bron-
chial tissue as proven by transbronchial biopsy [34].
Clinical and Histological Differential Diagnosis
The clinical differential diagnosis of GSS is constituted
by diseases with localized acquired lax skin due to local-
ized defects in elastic tissue [34]. Generalized cutis laxa
differs from GSS in that there is no tendency to involve
flexural areas while there is often involvement of the facial
skin and elastin tissue in other organs [34].
Anetoderma refers to an area of circumscribed slack
skin evolving to flaccid folds. This disorder may occur
associated with granulomatous inflammatory disease and
BCG vaccination [38]. In anetoderma, lesions are usually
smaller, the distribution of the lesions is at random and
there is no association with systemic elastolysis [34]. Jubert
et al. [35] reported on a patient with Sjögren’s syndrome
who developed numerous areas of slack skin and small
plaques on the trunk. The diagnosis anetoderma was made
and the patient appeared to have a multifocal cutaneous
plasmacytoma and a malignant B-cell lymphoma of the
parotid gland [35].
Mid-dermal elastolysis (MDE) is characterized by idio-
pathic wrinkling or wrinkling associated with clinical evi-
dence of inflammation. The wrinkling is circumscribed and
of the crinkle type, involving the entire skin surface in
otherwise healthy young or middle-aged women. There is
however no tendency to develop pendulous skin folds [39].
Kuramoto et al. [40] reported on a patient who devel-
oped an ‘elastolytic granuloma’ secondary to adult T-cell
leukemia. The dorsa of both hands, the face, the neck and
one thigh were affected. Laboratory data in this patient
revealed the presence of antibody to human T-cell leuke-
mia/lymphoma virus I. The cutaneous changes developed
in preexisting lymphomatous lesions but did not result in
bulky hanging skin lesions [40]. Finally, early lesions of
GSS may mimic MF and patches with poikiloderma have
been described in GSS [20].
Granulomatous inflammation has been noted in the cuta-
neous infiltrates of MF and Sézary syndrome of which
granulomatous MF (GMF) appears to be the most prevail-
ing [34]. In both diseases dermal band-like lymphocytic in-
filtrates can be found.
Epidermotropic MF cells and/or Pautrier’s microab-
scesses are rare in GSS. Fully developed GSS and GMF
can be discriminated by permeation of the dermis and the
subcutis by a granulomatous infiltrate and a complete loss
of elastic fibers in GSS, while in GMF a variable loss of
elastin is seen with low numbers and a different distribution
of granulomas and multinucleated giant cells.
In GSS the giant cells may contain up to 40 nuclei
per cell even in one section [32] in contrast to GMF where
up to 5–10 nuclei per cell can be present [3]. In GSS lym-
phophagocytosis is far more common than in GMF [13].
The atypia of lymphocyte nuclei in GSS is usually less
pronounced as compared to GMF and MF [3, 13, 25,
32–34].
The histology of MDE with inflammation is character-
ized by a perivascular inflammatory infiltrate, phagocytosis
of elastin by multinucleated giant cells (foreign-body type)
and mid-dermal loss of elastin, thus showing close resem-
blance to GSS apart from the lack of atypical lymphoid
cells in MDE [39].
Course and Prognosis
It appears that the skin lesions in GSS follow an indolent
course over more than 10 years with slow progression from
flexural areas to other skin sites. The disease itself is not
life-threatening. The prognosis is mainly determined by the
presence of a concomitant malignant lymphoproliferative
disease.
Associated Lymphoproliferative Diseases
The disease course of GSS may be complicated by the
development of a lymphoproliferative disease in both cuta-
neous and in extracutaneous sites or vice versa (table 2).
In 7 cases (21%), GSS was followed by HD [4–6, 8, 12,
15, 27, 33]. GSS was preceded by HD in 1 case [33]. GSS
and HD may present simultaneously [6], or HD may pre-
sent several years after the diagnosis of GSS has been made
[5, 12]. Even 11 years after the GSS diagnosis, the occur-
rence of HD has been described [15]. HD developed within
a GSS lesion in 1 case [8]. Other secondary malignant dis-
eases in GSS patients included Langerhans cell histiocyto-
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sis [30] and noncutaneous non-Hodgkin’s lymphomas [3, 7,
8, 12, 32]. GSS and MF presented simultaneously [11, 31]
or GSS developed in the axillary and inguinal folds that had
previously been affected by plaque-stage MF lesions (pa-
tient II of this study).
Treatment
To date, no treatment has resulted in complete remis-
sion. This is summarized in table 3.
Excision of diseased skin has been performed for cos-
metic or functional reasons [12, 25]. However, even when
diseased skin was totally excised, lesions recurred within
months. The only exception appears to be case 5 (table 3)
in whom no recurrence appeared after excision of a lesion
during a 2-year follow-up period [21]. Although reports
concerning treatment results and follow-up data in GSS are
scarce, it seems that in a proportion of the patients the same
treatment options, such as topical nitrogen mustard, PUVA
and UVB, that are given to patients with MF can also in-
duce remission in GSS [8, 14, 33, 34].
Pathobiology
Based on TCR gene rearrangement studies [2, 3, 8–10,
12, 13] and cytogenetic [10, 13] studies, it is suggested that
GSS results in fact from a clonal T-cell proliferation pre-
senting as an indolent granulomatous CTCL.
The pathobiology of GSS and notably its association
with lymphoproliferative malignancies, the cause of the
granuloma formation and its elastolysis, remains elusive.
GSS can be associated with preceding, concomitant and
subsequent lymphoproliferative disease in both cutaneous
and in extracutaneous sites in about 50% of the cases.
These are HD [4–6, 8, 12, 15, 27, 33], non-Hodgkin’s lym-
phoma [3, 7, 8, 12, 32], Langerhans cell histiocytosis [30]
and MF [11, 31] (table 2). It has been suggested that GSS
and HD represent cytogenetically related lymphoprolifera-
tive disorders. The finding of trisomy 8 in 2 patients with
GSS but without HD supports this hypothesis because this
numerical aberration has also been found in HD [13].
Involvement of chromosome 8 is uncommon in MF and
Sézary syndrome but has been reported in myeloid disor-
ders such as myelodysplastic syndrome, non-Hodgkin’s
lymphoma and acute myeloid leukemia [10].
It has also been suggested that in some cases GSS and
HD may potentially derive from one single T-cell clone
[15], a mechanism only proved in few patients with HD,
lymphomatoid papulosis and MF-type CTCL without GSS
[41, 42]. The case described by Le Boit (patient 9) [8] who
reported the occurrence of a nodule with histological fea-
tures of HD in a preexistent GSS lesion (no extracutaneous
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Table 2. Relationship between GSS and preexisting, accompany-
ing or subsequent lymphoproliferative malignancies (n= 34)
Presenting disease 2nd disease Cases, n
GSS HD 71
GSS NHL 3
GSS LCH 1
GSS not known/none 17
HD GSS 12
NHL GSS 1
GSS and MF simultaneously 2
MF GSS 13
HD and GSS simultaneously 1
Total 34
NHL= Non-Hodgkin’s lymphoma (nodal); LCH= Langerhans
cell histiocytosis.
1 GSS within HD lesion. One patient died of myelogenous leukemia
after a first diagnosis of GSS and a second diagnosis of HD.
2 HD within GSS lesion.
3 GSS within MF lesion.
Table 3. Response to treatment for GSS in 34 cases
Treatment(s) Response
PUVA PR (32)
Topical steroids PD (1, 32)
Excision RD (2, 3, 16, 33), CR (5)
(Poly)chemotherapy PR (11, 18, 25),
RD (10, 13), PD (28)
Systemic steroids PR (34), PR (21)
Nitrogen mustard PD (32)
Carmustine AD (33)
Radiotherapy AD (1, 8)
Azathioprine PR (2)
Interferon a PR (28)
Etretinate+ interferon a PR (27)
Interferon a + clofazimine PR (26)
Surgery+radiotherapy+ nitrogen mustard AD (14)
Polychemotherapy+radiotherapy RD (22)
Only the treatments that were given after the diagnosis of GSS
was made are represented. When more than one therapy was adminis-
tered to one patient, not as a combination, separate results are given.
Figures in parentheses indicate patient No. CR= Complete remission;
PR = partial remission; AD= arrest or slowing down of disease; PD=
progressive disease; RD= relapsing disease (after initial remission);
PUVA=ultraviolet A plus psoralen.
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HD was reported in this particular case) and case II pre-
sented by us with the development of GSS within preexis-
tent MF lesions stress the close relationship of GSS and
both HD and MF. The occurrence of two different lym-
phomas at one location is consistent with the definition of a
composite lymphoma [43], but this phenomenon is rare.
More insight into the relationship between GSS and the
other above-mentioned diseases can be obtained by TCR
gene clonality studies. However, these genotypic studies on
lymphoproliferative diseases in patients who also have GSS
have not yet been performed, so it is not yet known whether
GSS and associated disorders represent the same disease
with a rare clinical presentation in the skin or are separate
diseases.
Granuloma formation is a second characteristic phenom-
enon in GSS. Other granulomatous skin diseases which
show marked elastolysis include elastolytic giant cell gran-
uloma [36, 40] and MDE [39]. Granulomatous inflamma-
tion in association with malignant lymphoma may represent
an aberrant immunological response in patients with a dis-
ordered immune system either resulting from or perhaps
predisposing to lymphoma. This hypothesis is supported by
the presence of granuloma annulare in patients with malig-
nant lymphoma [37].
Alternatively the granulomatous inflammation might rep-
resent a peculiar host reaction to the lymphoid tumor cells
as part of the disease. Hermes et al. [36] hypothesized that
the granuloma formation in GSS may be the result of the
antigenic status of the atypical lymphocytes and/or elastic
fibers. In addition, granulomatous lymphadenitis has been
reported [33] in a patient with nodal HD and subsequent
GSS. This phenomenon may indicate immunological con-
trol.
However, there are reports of tumor progression in pa-
tients with GMF repudiating the claim that granulomatous
inflammation might be protective in CTCL [3, 45].
Our case III contributes to this discussion, because gran-
uloma formation was found in epithelial skin cancer, a skin
site which was clinically not involved by GSS. This sug-
gests that the granulomatous infiltrate in this patient repre-
sented a peculiar, nonspecific host reaction to tumor cells or
inflammation.
Another characteristic feature of GSS is complete loss
of dermal elastic fibers leading to lax skin formation. GSS
may be classified under the general heading ‘cutis laxa’
(dermatochalasia), a group of elastolysis syndromes [39,
44]. The pathophysiology of most of these syndromes re-
mains unknown. In acquired cutis laxa syndromes infil-
trates in the skin may directly or indirectly affect the struc-
ture of elastic fibers [44].
This elastic fiber phagocytosis may be a bystander phe-
nomenon of cytokine production involved in the activation
of histiocytic cells resulting in aspecific degradation and
phagocytosis of elastin [14].
A third explanation is given by Hwang et al. [44] who
postulated that acquired cutis laxa in general and possibly
syndromes such as MDE may be caused, at least in part, by
a 1-antitrypsin deficiency leading to a localized (or general-
ized) increase in granulocyte elastase activity. However, in
GSS the presence of this enzyme has not yet been investi-
gated.
Conclusions
Based on the characteristics of GSS and in analogy with
other syndromes with granuloma formation and elastolysis
it can be hypothesized that GSS is a rare variant of CTCL
of low-grade malignancy [46]. Therefore, pathologists
should look for the presence of atypical lymphoid cells in
punch biopsies from GSS lesions, and eventually TCR gene
clonality studies should be performed. GSS can be distin-
guished clinically and histologically from other CTCL by
the lax skin formation and granulomas with nearly com-
plete destruction of elastic fibers. It is a slowly progressive
disease presenting in the skin, but extracutaneous granulo-
mas may develop as well.
The association of GSS with preexisting or subsequent
lymphoproliferative diseases, especially HD, is an impor-
tant feature that warrants a long-term follow-up of patients
with GSS.
Surgery should be reserved only for cosmetically or
functionally disturbing lesions. Topical therapy may slow
down disease progression. Polychemotherapy should be re-
served for severe skin lesions that do not respond to topical
therapy or for treatment of extracutaneous manifestations.
Longitudinal comparative TCR gene clonality studies or
comparative retrospective analysis of skin biopsies in GSS
patients might provide more insight into the precise rela-
tionship between GSS and other preexisting or subsequent
lymphoproliferative diseases. This is especially important
for understanding whether GSS, MF and HD are directly
related or represent separate diseases which develop in a
susceptible patient.
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